Related Experiment Video
Updated: Aug 15, 2025

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
Heterogeneous circulating miRNA profiles of PBMAH
Kazunari Hara1, Masanori Murakami1, Yoshihiro Niitsu1
1Department of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
Primary bilateral macronodular adrenal hyperplasia (PBMAH) has a unique circulating microRNA (miRNA) signature. This finding may explain the varying disease presentations in PBMAH patients.
Area of Science:
- Endocrinology
- Molecular Biology
- Genomics
Background:
- Primary bilateral macronodular adrenal hyperplasia (PBMAH) is a rare cause of Cushing syndrome, often presenting as bilateral adrenal incidentalomas with subclinical cortisol production.
- Circulating microRNAs (miRNAs) are known biomarkers for adrenocortical adenomas, but their expression in PBMAH remains uninvestigated.
Purpose of the Study:
- To investigate and characterize the circulating miRNA expression profiles in patients with PBMAH.
- To compare these profiles with those found in patients with non-functioning adrenocortical adenoma (NFA) and cortisol-producing adrenocortical adenoma (CPA).
Main Methods:
- Plasma samples were collected from patients diagnosed with NFA (4), CPA (5), and PBMAH (5).
- Comprehensive miRNA profiling was performed on these samples.
- Quantitative reverse transcription-polymerase chain reaction (RT-PCR) was employed to validate the expression of selected miRNAs.
Main Results:
- Hierarchical clustering revealed distinct miRNA expression signatures for PBMAH, separate from NFA and CPA samples.
- A total of 135 differentially expressed miRNAs distinguished PBMAH from other adenoma types.
- Specific miRNAs (hsa-miR-1180-3p, hsa-miR-4732-5p, hsa-let-7b-5p) showed significant differential expression between PBMAH and adenomas (P ≤ 0.019).
- PBMAH samples could be classified into two subtypes based on miRNA profiles, with subtype 2 exhibiting distinct expression patterns compared to adenomas.
Conclusions:
- A specific circulating miRNA signature has been identified for PBMAH.
- The observed subtype-based miRNA profiles suggest underlying pathophysiological heterogeneity within PBMAH.
More Related Videos
10:37Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
07:55Harnessing the Power of MicroRNA Cargoes in Small Extracellular Vesicles Released from Fresh-Frozen Human Brain Sections
Published on: November 8, 2024